Discrepancy of interleukin‐6 levels between end‐stage renal disease patients and patients with acute‐phase response with increased lipoprotein(a) concentrations

References

• Gaubatz JW, Heideman C, Gotto AM, Jr, Morrisett JD, Dahlen GH. Human plasma lipoprotein [a]. Structural properties. J Biol Chem 1983; 258: 4582–9.
   Google Scholar
• Fless GM, ZumMallen ME, Scanu AM. Isolation of apolipoprotein(a) from lipoprotein(a). J Lipid Res 1985; 26: 1224–9.
   Google Scholar
• Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904–10.
   PubMed Web of Science ®Google Scholar
• McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132–7.
   PubMed Web of Science ®Google Scholar
• Gaubatz JW, Ghanem KI, Guevara J, Jr, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res 1990; 31: 603–13.
   Google Scholar
• Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein pheno-types. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458–65.
   Google Scholar
• Boerwinkle E, Menzel HJ, Kraft HG, Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet 1989; 82: 73–8.
   Google Scholar
• Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52–60.
   PubMed Web of Science ®Google Scholar
• Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, Konig P. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993; 91: 397 — 401.
   PubMed Web of Science ®Google Scholar
• de Bruin TW, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ, Erkelens DW. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid sub-jects. J Clin Endocrinol Metab 1993; 76: 121–6.
   PubMed Web of Science ®Google Scholar
• Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993; 13: 296— 301.
   Google Scholar
• Olivecrona H, Ericsson S, Berglund L, Angelin B. Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment. Br Med J 1993; 306: 1726–7.
   PubMed Web of Science ®Google Scholar
• Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994; 154: 1106–10.
   Google Scholar
• Min WK, Lee JO, Huh JW. Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for cor-onary heart disease. Clin Chem 1997; 43: 1891–5.
   Google Scholar
• Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237–9.
   PubMed Web of Science ®Google Scholar
• Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181: 257–66.
   PubMed Web of Science ®Google Scholar
• Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999; 19: 141–55.
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ, Whicher JT. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995; 102: 217–23.
   PubMed Web of Science ®Google Scholar
• Delarue J, Husson M, Schellenberg F, Tichet J, Vol S, Couet C, Lamisse F. Serum lipoprotein(a) [Lp(a)] in alcoholic men: effect of withdrawal. Alcohol 1996; 13: 309–14.
   Google Scholar
• Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Biol 1997; 17: 1822— 9.
   Google Scholar
• Ramharack R, Barkalow D, Spahr MA. Domi-nant negative effect of TGF-beta 1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in pri-mary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 1998; 18: 984–90.
   Google Scholar
• Hattori M, Abraham LJ, Northemann W, Fey GH. Acute-phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat alpha 2-macroglobulin gene. Proc Natl Acad Sci USA 1990; 87: 2364–8.
   PubMed Web of Science ®Google Scholar
• Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K, Schwartz K, Lawn RM. 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 1993; 90: 1369–73.
   PubMed Web of Science ®Google Scholar
• Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Athero-sclerosis 1989; 78: 145–50.
   PubMed Web of Science ®Google Scholar
• Anderson J, Briefel G, Jones JM, Ryu JH, McGuire M, Yun YP. Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels. Kidney Int 1991; 40: 1110–7.
   PubMed Web of Science ®Google Scholar
• Kario K, Matsuo T, Kobayashi H, Matsuo M, Asada R, Koide M. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb Haemost 1995; 74: 1020–4.
   PubMed Web of Science ®Google Scholar
• Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998; 31: 93–100.
   PubMed Web of Science ®Google Scholar
• Oida K, Takai H, Maeda H, Takahashi S, Shimada A, Suzuki J, Tamai T, Nakai T, Miyabo S. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38: 2244–8.
   Google Scholar
• Kronenberg F, Trenkwalder E, Lingenhel A, Friedrich G, Lhotta K, Schober M, Moes N, Konig P, Utermann G, Dieplinger H. Renovas-cular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation. J Lipid Res 1997; 38: 1755–63.
   PubMed Web of Science ®Google Scholar
• Kostner KM, Maurer G, Huber K, Stefenelli T, Dieplinger H, Steyrer E, Kostner GM. Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Arterioscler Thromb Biol 1996; 16: 905–11.
   PubMed Web of Science ®Google Scholar